18 research outputs found
Recommended from our members
Intake of dairy foods and oral health: review of epidemiological data
Introduction: The relationship between diet and oral health is intriguing. Various components of milk have been suggested to be protective against oral health problems, although specific mechanisms linking dairy components to the pathogenesis of certain diseases are still unclear.
Purpose: To provide an overview of the associations between intake of milk and dairy products and dental plaque, periodontal disease and tooth loss based on currently available literature.
Methods: We performed a review of relevant literature with critical appraisal of those human epidemiological studies evaluating the association between intake of milk or dairy products and periodontal disease, plaque score or tooth loss among adults and elderly.
Results: Nine studies were included in the review, eight of which were cross-sectional and only one applied a longitudinal design. None of the studies included institutionalised participants. Overall, reported studies suggested an inverse association between dairy intake and plaque score and periodontal disease. Results related to tooth loss were inclusive.
Conclusion: The methodological quality of reviewed studies was moderate to low with only one longitudinal design. Therefore, well-designed, confounding-controlled, longitudinal studies are warranted to be able to conclude on the potential protective effect of dairy intake on periodontal disease, dental plaque and tooth loss
Recommended from our members
The effect of vitamin D and/or Calcium supplementation on periodontitis
Objective:
To perform a systematic review and assess whether the use of vitamin D and calcium supplements can beneļ¬t the prevention of periodontitis and tooth loss among adults and elderly.
Method:
Research of MEDLINE, LILACS, Cochrane Library, Scopus and ClinicalTrials.gov and reference lists of relevant papers to identify experimental and observational studies on the effect of vitamin D and/or calcium supplementation on clinical parameters of periodontitis. Primary outcomes were clinical attachment loss (CAL), probing depth (PD) and tooth loss.
Results:
Four studies were included. Meta-analysis across studies showed a standardized mean difference (SMD) of ā0.194 (95% CI: ā0.777 to 0.389) and ā0.168 (95% CI: ā0.736 to 0.400) for CAL and PD, respectively.
Conclusion:
Vitamin D and calcium supplementation seem to have some beneļ¬cial effect on clinical parameters of periodontitis as a complementary therapy. However, these ļ¬ndings need to be conļ¬rmed before being used in clinical practice
Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019 : results from the Global Burden of Disease Study 2019
BACKGROUND: The global burden of lower respiratory infections (LRIs) and corresponding risk factors in children older than 5 years and adults has not been studied as comprehensively as it has been in children younger than 5 years. We assessed the burden and trends of LRIs and risk factors across all age groups by sex, for 204 countries and territories. METHODS: In this analysis of data for the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, we used clinician-diagnosed pneumonia or bronchiolitis as our case definition for LRIs. We included International Classification of Diseases 9th edition codes 079.6, 466-469, 470.0, 480-482.8, 483.0-483.9, 484.1-484.2, 484.6-484.7, and 487-489 and International Classification of Diseases 10th edition codes A48.1, A70, B97.4-B97.6, J09-J15.8, J16-J16.9, J20-J21.9, J91.0, P23.0-P23.4, and U04-U04.9. We used the Cause of Death Ensemble modelling strategy to analyse 23ā109 site-years of vital registration data, 825 site-years of sample vital registration data, 1766 site-years of verbal autopsy data, and 681 site-years of mortality surveillance data. We used DisMod-MR 2.1, a Bayesian meta-regression tool, to analyse age-sex-specific incidence and prevalence data identified via systematic reviews of the literature, population-based survey data, and claims and inpatient data. Additionally, we estimated age-sex-specific LRI mortality that is attributable to the independent effects of 14 risk factors. FINDINGS: Globally, in 2019, we estimated that there were 257 million (95% uncertainty interval [UI] 240-275) LRI incident episodes in males and 232 million (217-248) in females. In the same year, LRIs accounted for 1ĆĀ·30 million (95% UI 1ĆĀ·18-1ĆĀ·42) male deaths and 1ĆĀ·20 million (1ĆĀ·07-1ĆĀ·33) female deaths. Age-standardised incidence and mortality rates were 1ĆĀ·17 times (95% UI 1ĆĀ·16-1ĆĀ·18) and 1ĆĀ·31 times (95% UI 1ĆĀ·23-1ĆĀ·41) greater in males than in females in 2019. Between 1990 and 2019, LRI incidence and mortality rates declined at different rates across age groups and an increase in LRI episodes and deaths was estimated among all adult age groups, with males aged 70 years and older having the highest increase in LRI episodes (126ĆĀ·0% [95% UI 121ĆĀ·4-131ĆĀ·1]) and deaths (100ĆĀ·0% [83ĆĀ·4-115ĆĀ·9]). During the same period, LRI episodes and deaths in children younger than 15 years were estimated to have decreased, and the greatest decline was observed for LRI deaths in males younger than 5 years (-70ĆĀ·7% [-77ĆĀ·2 to -61ĆĀ·8]). The leading risk factors for LRI mortality varied across age groups and sex. More than half of global LRI deaths in children younger than 5 years were attributable to child wasting (population attributable fraction [PAF] 53ĆĀ·0% [95% UI 37ĆĀ·7-61ĆĀ·8] in males and 56ĆĀ·4% [40ĆĀ·7-65ĆĀ·1] in females), and more than a quarter of LRI deaths among those aged 5-14 years were attributable to household air pollution (PAF 26ĆĀ·0% [95% UI 16ĆĀ·6-35ĆĀ·5] for males and PAF 25ĆĀ·8% [16ĆĀ·3-35ĆĀ·4] for females). PAFs of male LRI deaths attributed to smoking were 20ĆĀ·4% (95% UI 15ĆĀ·4-25ĆĀ·2) in those aged 15-49 years, 30ĆĀ·5% (24ĆĀ·1-36ĆĀ·9) in those aged 50-69 years, and 21ĆĀ·9% (16ĆĀ·8-27ĆĀ·3) in those aged 70 years and older. PAFs of female LRI deaths attributed to household air pollution were 21ĆĀ·1% (95% UI 14ĆĀ·5-27ĆĀ·9) in those aged 15-49 years and 18ĆĀ·2% (12ĆĀ·5-24ĆĀ·5) in those aged 50-69 years. For females aged 70 years and older, the leading risk factor, ambient particulate matter, was responsible for 11ĆĀ·7% (95% UI 8ĆĀ·2-15ĆĀ·8) of LRI deaths. INTERPRETATION: The patterns and progress in reducing the burden of LRIs and key risk factors for mortality varied across age groups and sexes. The progress seen in children younger than 5 years was clearly a result of targeted interventions, such as vaccination and reduction of exposure to risk factors. Similar interventions for other age groups could contribute to the achievement of multiple Sustainable Development Goals targets, including promoting wellbeing at all ages and reducing health inequalities. Interventions, including addressing risk factors such as child wasting, smoking, ambient particulate matter pollution, and household air pollution, would prevent deaths and reduce health disparities. FUNDING: Bill & Melinda Gates Foundation
Global, regional, and national burden of meningitis and its aetiologies, 1990ā2019: a systematic analysis for the Global Burden of Disease Study 2019
Background
Although meningitis is largely preventable, it still causes hundreds of thousands of deaths globally each year. WHO set ambitious goals to reduce meningitis cases by 2030, and assessing trends in the global meningitis burden can help track progress and identify gaps in achieving these goals. Using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, we aimed to assess incident cases and deaths due to acute infectious meningitis by aetiology and age from 1990 to 2019, for 204 countries and territories.
Methods
We modelled meningitis mortality using vital registration, verbal autopsy, sample-based vital registration, and mortality surveillance data. Meningitis morbidity was modelled with a Bayesian compartmental model, using data from the published literature identified by a systematic review, as well as surveillance data, inpatient hospital admissions, health insurance claims, and cause-specific meningitis mortality estimates. For aetiology estimation, data from multiple causes of death, vital registration, hospital discharge, microbial laboratory, and literature studies were analysed by use of a network analysis model to estimate the proportion of meningitis deaths and cases attributable to the following aetiologies: Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae, group B Streptococcus, Escherichia coli, Klebsiella pneumoniae, Listeria monocytogenes, Staphylococcus aureus, viruses, and a residual other pathogen category.
Findings
In 2019, there were an estimated 236ā000 deaths (95% uncertainty interval [UI] 204ā000ā277ā000) and 2Ā·51 million (2Ā·11ā2Ā·99) incident cases due to meningitis globally. The burden was greatest in children younger than 5 years, with 112ā000 deaths (87ā400ā145ā000) and 1Ā·28 million incident cases (0Ā·947ā1Ā·71) in 2019. Age-standardised mortality rates decreased from 7Ā·5 (6Ā·6ā8Ā·4) per 100ā000 population in 1990 to 3Ā·3 (2Ā·8ā3Ā·9) per 100ā000 population in 2019. The highest proportion of total all-age meningitis deaths in 2019 was attributable to S pneumoniae (18Ā·1% [17Ā·1ā19Ā·2]), followed by N meningitidis (13Ā·6% [12Ā·7ā14Ā·4]) and K pneumoniae (12Ā·2% [10Ā·2ā14Ā·3]). Between 1990 and 2019, H influenzae showed the largest reduction in the number of deaths among children younger than 5 years (76Ā·5% [69Ā·5ā81Ā·8]), followed by N meningitidis (72Ā·3% [64Ā·4ā78Ā·5]) and viruses (58Ā·2% [47Ā·1ā67Ā·3]).
Interpretation
Substantial progress has been made in reducing meningitis mortality over the past three decades. However, more meningitis-related deaths might be prevented by quickly scaling up immunisation and expanding access to health services. Further reduction in the global meningitis burden should be possible through low-cost multivalent vaccines, increased access to accurate and rapid diagnostic assays, enhanced surveillance, and early treatment.publishedVersio
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950ā2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
Background: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 countries and territories and 811 additional subnational locations from 1950 to 2021, with a particular emphasis on changes in mortality and life expectancy that occurred during the 2020ā21 COVID-19 pandemic period. Methods: 22 223 data sources from vital registration, sample registration, surveys, censuses, and other sources were used to estimate mortality, with a subset of these sources used exclusively to estimate excess mortality due to the COVID-19 pandemic. 2026 data sources were used for population estimation. Additional sources were used to estimate migration; the effects of the HIV epidemic; and demographic discontinuities due to conflicts, famines, natural disasters, and pandemics, which are used as inputs for estimating mortality and population. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate under-5 mortality rates, which synthesised 30 763 location-years of vital registration and sample registration data, 1365 surveys and censuses, and 80 other sources. ST-GPR was also used to estimate adult mortality (between ages 15 and 59 years) based on information from 31 642 location-years of vital registration and sample registration data, 355 surveys and censuses, and 24 other sources. Estimates of child and adult mortality rates were then used to generate life tables with a relational model life table system. For countries with large HIV epidemics, life tables were adjusted using independent estimates of HIV-specific mortality generated via an epidemiological analysis of HIV prevalence surveys, antenatal clinic serosurveillance, and other data sources. Excess mortality due to the COVID-19 pandemic in 2020 and 2021 was determined by subtracting observed all-cause mortality (adjusted for late registration and mortality anomalies) from the mortality expected in the absence of the pandemic. Expected mortality was calculated based on historical trends using an ensemble of models. In location-years where all-cause mortality data were unavailable, we estimated excess mortality rates using a regression model with covariates pertaining to the pandemic. Population size was computed using a Bayesian hierarchical cohort component model. Life expectancy was calculated using age-specific mortality rates and standard demographic methods. Uncertainty intervals (UIs) were calculated for every metric using the 25th and 975th ordered values from a 1000-draw posterior distribution. Findings: Global all-cause mortality followed two distinct patterns over the study period: age-standardised mortality rates declined between 1950 and 2019 (a 62Ā·8% [95% UI 60Ā·5ā65Ā·1] decline), and increased during the COVID-19 pandemic period (2020ā21; 5Ā·1% [0Ā·9ā9Ā·6] increase). In contrast with the overall reverse in mortality trends during the pandemic period, child mortality continued to decline, with 4Ā·66 million (3Ā·98ā5Ā·50) global deaths in children younger than 5 years in 2021 compared with 5Ā·21 million (4Ā·50ā6Ā·01) in 2019. An estimated 131 million (126ā137) people died globally from all causes in 2020 and 2021 combined, of which 15Ā·9 million (14Ā·7ā17Ā·2) were due to the COVID-19 pandemic (measured by excess mortality, which includes deaths directly due to SARS-CoV-2 infection and those indirectly due to other social, economic, or behavioural changes associated with the pandemic). Excess mortality rates exceeded 150 deaths per 100 000 population during at least one year of the pandemic in 80 countries and territories, whereas 20 nations had a negative excess mortality rate in 2020 or 2021, indicating that all-cause mortality in these countries was lower during the pandemic than expected based on historical trends. Between 1950 and 2021, global life expectancy at birth increased by 22Ā·7 years (20Ā·8ā24Ā·8), from 49Ā·0 years (46Ā·7ā51Ā·3) to 71Ā·7 years (70Ā·9ā72Ā·5). Global life expectancy at birth declined by 1Ā·6 years (1Ā·0ā2Ā·2) between 2019 and 2021, reversing historical trends. An increase in life expectancy was only observed in 32 (15Ā·7%) of 204 countries and territories between 2019 and 2021. The global population reached 7Ā·89 billion (7Ā·67ā8Ā·13) people in 2021, by which time 56 of 204 countries and territories had peaked and subsequently populations have declined. The largest proportion of population growth between 2020 and 2021 was in sub-Saharan Africa (39Ā·5% [28Ā·4ā52Ā·7]) and south Asia (26Ā·3% [9Ā·0ā44Ā·7]). From 2000 to 2021, the ratio of the population aged 65 years and older to the population aged younger than 15 years increased in 188 (92Ā·2%) of 204 nations. Interpretation: Global adult mortality rates markedly increased during the COVID-19 pandemic in 2020 and 2021, reversing past decreasing trends, while child mortality rates continued to decline, albeit more slowly than in earlier years. Although COVID-19 had a substantial impact on many demographic indicators during the first 2 years of the pandemic, overall global health progress over the 72 years evaluated has been profound, with considerable improvements in mortality and life expectancy. Additionally, we observed a deceleration of global population growth since 2017, despite steady or increasing growth in lower-income countries, combined with a continued global shift of population age structures towards older ages. These demographic changes will likely present future challenges to health systems, economies, and societies. The comprehensive demographic estimates reported here will enable researchers, policy makers, health practitioners, and other key stakeholders to better understand and address the profound changes that have occurred in the global health landscape following the first 2 years of the COVID-19 pandemic, and longer-term trends beyond the pandemic
Intake of Dairy Products in Relation to Periodontitis in Older Danish Adults
This cross-sectional study investigates whether calcium intakes from dairy and non-dairy sources, and absolute intakes of various dairy products, are associated with periodontitis. The calcium intake (mg/day) of 135 older Danish adults was estimated by a diet history interview and divided into dairy and non-dairy calcium. Dairy food intake (g/day) was classified into four groups: milk, cheese, fermented foods and other foods. Periodontitis was defined as the number of teeth with attachment loss ā„3 mm. Intakes of total dairy calcium (Incidence-rate ratio (IRR) = 0.97; p = 0.021), calcium from milk (IRR = 0.97; p = 0.025) and fermented foods (IRR = 0.96; p = 0.03) were inversely and significantly associated with periodontitis after adjustment for age, gender, education, sucrose intake, alcohol consumption, smoking, physical activity, vitamin D intake, heart disease, visits to the dentist, use of dental floss and bleeding on probing, but non-dairy calcium, calcium from cheese and other types of dairy food intakes were not. Total dairy foods (IRR = 0.96; p = 0.003), milk (IRR = 0.96; p = 0.028) and fermented foods intakes (IRR = 0.97; p = 0.029) were associated with reduced risk of periodontitis, but cheese and other dairy foods intakes were not. These results suggest that dairy calcium, particularly from milk and fermented products, may protect against periodontitis. Prospective studies are required to confirm these findings
Influence of parental overweight on the association of birth weight and fat distribution later in childhood
Objective: To examine whether the association between birth weight and fat distribution in childhood is modified by parental overweight. Methods: Cross-sectional study of 728 Danish children aged 8ā10 and 14ā16 years. The main outcomes were waist circumference, waist-to-height ratio, subscapular skinfold, and subscapular-to-triceps skinfold ratio. Analyses were stratified by parental overweight status (none vs. ā„1 overweight parent) for each dependent variable, expressed as z-scores. Results: Birth weight z-score was negatively associated with waist circumference (Ī² ā0.08 SD; 95% CI ā0.15, ā0.02), waist-to-height ratio (Ī² ā0.15 SD; 95% CI ā0.22, ā0.07), and subscapular-to-triceps ratio (Ī² ā0.28 SD; 95% CI ā0.44, ā0.12) after adjustment for sex, age, puberty, preterm birth, BMI, height, socio-economic status, motherās age at delivery, parity, breastfeeding, energy intake, and aerobic fitness in the group with ā„1 overweight parent. Birth weight was negatively associated with subscapular skinfold in groups with (Ī² ā0.16 SD; 95% CI ā0.24, ā0.06) and without overweight parents (Ī² ā0.09 SD; 95% CI ā0.16, ā0.02), but the magnitude of the association was greater in the former group. Conclusion: The association between birth weight and fat distribution seems to be influenced by parental overweight. Lower birth weights are associated with central adiposity among offspring of overweight parents